Cancer Diagnostic Market Fueled by Early Detection Technologies and AI-Powered Imaging | F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc.

The global cancer diagnostics market reached US$ 21.71 billion in 2024 and is expected to reach US$ 42.64 billion by 2033, growing at a CAGR of 8.7% during the forecast period of 2025-2033.

Cancer Diagnostic Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising global cancer incidence, advancements in imaging and biomarker platforms, and increasing investment in early detection, the report delivers strategic insights for stakeholders across the cancer diagnostics ecosystem from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cancer-diagnostic-market?ophp

Cancer diagnostics encompass imaging, biopsy, and molecular testing techniques to detect and monitor cancer. Rising cancer burden, early detection awareness, and advancements in liquid biopsy and AI-powered imaging are fueling global market expansion.

Cancer Diagnostic Market Competitors Overview:

F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, GE HealthCare, Illumina, Inc., Bio-Rad Laboratories, Inc., Hologic, Inc., Koninklijke Philips N.V., BD, and QIAGEN, among others.

Important Industry Updates of 2024 and 2025:

✅ In January 2025, Roche received FDA approval for a companion diagnostic-a test designed to identify patients who are most likely to benefit from a specific treatment. In this case, the test determines whether patients with HER2-ultralow metastatic breast cancer are eligible for treatment with ENHERTU.

✅ In September 2024, Roche announced an expansion of its digital pathology platform by integrating over 20 advanced AI algorithms from eight new collaborators. Digital pathology involves scanning traditional glass microscope slides and analyzing them using digital tools, including AI, to improve diagnostic accuracy and efficiency.

Methodology and Scope

The Cancer Diagnostic Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cancer-diagnostic-market?ophp

Cancer Diagnostic Market Segments Overview:

∎ By Product Type (Consumables, Antibodies, Kits & Reagents, Probes, Others, Instruments, Pathology-based, Tissue Processing Systems, Cell Processors, PCR Instruments, Microarrays, Others, Imaging, CT Systems, Ultrasound Systems, MRI Systems, Mammography Systems, Others)
∎ By Technology (IVD Testing, In Situ Hybridization (ISH), Next-generation Sequencing (NGS), Imaging, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Others)
∎ By Cancer Type (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Others)
∎ By End User (Hospitals and Clinics, Diagnostic Laboratories, Cancer Care and Research Institutes, Others)

The imaging (CT, MRI, PET) segment dominates the market because of its critical role in identifying tumor location, stage, and progression in nearly all cancer types.

Regional Overview for Cancer Diagnostic Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America dominates due to advanced imaging and liquid biopsy use. Asia Pacific is the fastest growing, supported by increasing cancer prevalence and early screening efforts.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cancer-diagnostic-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Cancer Diagnostic market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cancer Diagnostic market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.